← All trials
NCT06423898
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 9, 2024
- Primary completion
- Jul 31, 2027
- Completion date
- Dec 31, 2028
- First posted
- May 21, 2024
- Last posted
- Jul 25, 2025
- Enrollment
- 284
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Fundación Pública AndaluzaLead sponsor
- Spanish Clinical Research NetworkCollaborator
- IVI SevillaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.